Inhaler testing equipment maker Copley Scientific has announced the appointment of Clair Brooks as Applications Specialist "to maintain a customer-centric focus as growth continues." Brooks was most recently a field application specialist at Primerdesign, a maker of PCR kits. Copley Managing Director Jamie Clayton commented, "The role of applications specialist … [Read more...] about Copley Scientific hires Clair Brooks as Applications Specialist
Products and Services
CounterAct announces completion of human factors / usability study
CounterAct has announced results from a human factors / usability study of its nasal spray cap device that included a simulated rescue in an opioid overdose scenario. The CounterAct device, which is designed to snap onto a prescription pill bottle, contains a single dose of naloxone. According to the company, the average time required for participants in the study to … [Read more...] about CounterAct announces completion of human factors / usability study
Experic adds spray drying services
CDMO Experic announced that it is adding a pilot scale spray dryer spray at its facility in Cranbury, NJ, USA, extending the company's DPI formulation development capabilities. According to Experic, installation and validation of the new spray dryer are expected to be complete by July 2023. The company said that the spray drying services will complement its … [Read more...] about Experic adds spray drying services
PARI acquires equine nebulizer maker Nortev
Nebulizer manufacturer PARI announced that it has acquired equine nebulizer maker Nortev in a deal that the company suggested "opens attractive synergy potential." Nortev will continue to operate independently, the company said. According to PARI, Nortev also sells nebulizers for small pets in addition to its Flexineb device for horses, which is sold in more than 30 … [Read more...] about PARI acquires equine nebulizer maker Nortev
Nanoform announces completion of successful GMP inspection
Nanoparticle technology specialist Nanoform Finland has announced the completion of a successful GMP inspection of its API manufacturing facility by the Finnish Medicines Agency (FIMEA). The company said that the agency issued no critical or major observations following the March 28, 2023 inspection, and the company's license was renewed. An independent GMP auditor … [Read more...] about Nanoform announces completion of successful GMP inspection
Strides and Orbicular partner on development of nasal sprays
Generics manufacturer Strides Pharma Science and CRO Orbicular Pharmaceutical Technologies, both based in India, have announced a new strategic partnership where Orbicular will formulate 4 nasal sprays to be manufactured and commercialized by Strides. According to the announcement, Strides will manufacture the nasal sprays at its facility in Chestnut Ridge, NY, USA … [Read more...] about Strides and Orbicular partner on development of nasal sprays
H&T Presspart and Hovione announce partnership for development of new DPI platform
Device developer and manufacturer H&T Presspart and particle engineering/spray drying specialist Hovione have announced an expansion of their existing relationship with an agreement for development of H&T Presspart's new Sunriser DPI technology. The two companies have previously partnered on development of the PowdAir Plus capsule-based dry powder inhaler. … [Read more...] about H&T Presspart and Hovione announce partnership for development of new DPI platform
Copley Scientific launches Impactor Genie IG 200i
Copley Scientific has announced the launch of the Impactor Genie IG 200i semi-automated tool for impaction surface coating and drug dissolution that can be used with either Andersen cascade impactors or Next Generation Impactors. According to Copley, the Impactor Genie IG 200i combines the functions of the new Impactor Coater IC 200i, which can coat collection cups … [Read more...] about Copley Scientific launches Impactor Genie IG 200i
GSK gives up exclusive license for use of Liquidia’s PRINT particle technology for inhaled formulations
Liquidia Corporation said that a new agreement will supersede its 2012 license agreement with GSK that gave GSK exclusive rights to develop certain inhaled formulations based on Liquidia's PRINT particle engineering technology. In 2015, GSK exercised an option giving it exclusive worldwide rights to develop PRINT formulations of inhaled therapies, with the exception … [Read more...] about GSK gives up exclusive license for use of Liquidia’s PRINT particle technology for inhaled formulations
Catalent to manufacture HRT’s RiVive naloxone nasal spray
Catalent and Harm Reduction Therapeutics (HRT) announced that they have signed a commercial supply agreement for the manufacture of HRT's RiVive intranasal naloxone. The news comes shortly after HRT said that it would receive an additional $9 million in funding from Purdue Pharma that would be used to prepare for possible commercialization of RiVive. The FDA … [Read more...] about Catalent to manufacture HRT’s RiVive naloxone nasal spray